Novadip Biosciences raises €10.4M
Novadip Biosciences announced a Debt round of €10.4M on 21 September 2026. The company operates in HealthTech and is based in Belgium. It was founded by Denis Dufrane, Founder & CEO. Announced yesterday.
Founder
Denis Dufrane
Founder & CEO, Novadip Biosciences
Outreach angles
- -Dr. Denis Dufrane founded Novadip Biosciences in 2013 based on his research at Université Catholique de Louvain.
- -Novadip has raised €137 million in total equity and non-dilutive funding since inception.
- -The new financing unlocks an €18 million EIB venture debt tranche and funds completion of Phase 3 trials for its bone-regeneration therapy NVD003.
Signals
DebtHealthcareRegulated IndustryDeep TechB2B
Round details
Company: Novadip Biosciences
Domain: novadip.com
Amount: €10.4M
Stage: Debt
Industry: HealthTech
Country: Belgium
Announced: 21 September 2026
Other HealthTech raises
Recently funded in Belgium